Basel, Germany 4/23/13; London, UK 4/23/13—Roche has announced that it is dissolving its Applied Science business, part of its Diagnostics Division, and integrating the product lines into other Diagnostics Business Areas. A new unit will be established to focus solely on sequencing, including the current sequencing business, but the company will cease its sequencer development […]
The first of IBO’s biannual new laboratory roundup focuses on new facilities for cancer treatment and research, along with new genetically modified (GM) crop labs and consumer products labs. In addition, the table on page 6 highlights plans for new labs for the automotive, pharmaceutical and semiconductor industries. Three organizations, including two universities, have announced […]
IBO’s first patent litigation article for 2013 summarizes new patent infringement litigation involving instrument and lab product companies, as well as settlements and development in ongoing suits. New Suits In the US District Court of Delaware, Illumina is the defendant in a case brought by optics firm Cirrex Systems (see table, page 3). Cirrex alleges […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
